Co-Authors
This is a "connection" page, showing publications co-authored by Elissa Abrams and Matthew Greenhawt.
Connection Strength
8.867
-
COVID-19 vaccines: addressing hesitancy in young people with allergies. Lancet Respir Med. 2021 10; 9(10):1090-1092.
Score: 0.962
-
School Attendance, Asthma Risk, and COVID-19 in Children. J Allergy Clin Immunol Pract. 2021 06; 9(6):2145-2150.
Score: 0.935
-
What the COVID-19 Pandemic Can Teach Us About Resource Stewardship and Quality in Health Care. J Allergy Clin Immunol Pract. 2021 02; 9(2):608-612.
Score: 0.916
-
Mitigating Misinformation and Changing the Social Narrative. J Allergy Clin Immunol Pract. 2020 Nov - Dec; 8(10):3261-3263.
Score: 0.898
-
The Challenges and Opportunities for Shared Decision Making Highlighted by COVID-19. J Allergy Clin Immunol Pract. 2020 09; 8(8):2474-2480.e1.
Score: 0.892
-
Risk Communication During COVID-19. J Allergy Clin Immunol Pract. 2020 06; 8(6):1791-1794.
Score: 0.877
-
The Risk of Allergic Reaction to SARS-CoV-2 Vaccines and Recommended Evaluation and Management: A Systematic Review, Meta-Analysis, GRADE Assessment, and International Consensus Approach. J Allergy Clin Immunol Pract. 2021 10; 9(10):3546-3567.
Score: 0.238
-
The Revenge of Unintended Consequences of Anaphylaxis-Risk Overdiagnosis: How Far We Have Come and How Far We Have to Go. J Allergy Clin Immunol Pract. 2021 11; 9(11):3911-3917.
Score: 0.238
-
Reply to "How important is the second dose of the COVID-19 mRNA vaccine?" J Allergy Clin Immunol Pract. 2021 06; 9(6):2537-2539.
Score: 0.237
-
Primary care provider-reported prevalence of vaccine and polyethylene glycol allergy in Canada. Ann Allergy Asthma Immunol. 2021 10; 127(4):446-450.e1.
Score: 0.236
-
The Importance of a Timely Second Dose of the 2021 COVID-19 mRNA Vaccine Depends on the Protection Afforded by a First Dose and Subsequent Risk of Anaphylaxis. J Allergy Clin Immunol Pract. 2021 07; 9(7):2556-2561.
Score: 0.235
-
Ten tips for improving your clinical practice during the COVID-19 pandemic. Curr Opin Pediatr. 2021 Apr 01; 33(2):260-267.
Score: 0.234
-
A Cost-Effectiveness Evaluation of Hospitalizations, Fatalities, and Economic Outcomes Associated with Universal Versus Anaphylaxis Risk-Stratified COVID-19 Vaccination Strategies. J Allergy Clin Immunol Pract. 2021 07; 9(7):2658-2668.e3.
Score: 0.233
-
Media Influence on Anxiety, Health Utility, and Health Beliefs Early in the SARS-CoV-2 Pandemic-a Survey Study. J Gen Intern Med. 2021 05; 36(5):1327-1337.
Score: 0.233
-
The COVID-19 Pandemic in 2021: Avoiding Overdiagnosis of Anaphylaxis Risk While Safely Vaccinating the World. J Allergy Clin Immunol Pract. 2021 04; 9(4):1438-1441.
Score: 0.232
-
Novel Approaches to Food Allergy Management During COVID-19 Inspire Long-Term Change. J Allergy Clin Immunol Pract. 2020 10; 8(9):2851-2857.
Score: 0.224
-
Managing Food Allergy in Schools During the COVID-19 Pandemic. J Allergy Clin Immunol Pract. 2020 10; 8(9):2845-2850.
Score: 0.223
-
A Phased Approach to Resuming Suspended Allergy/Immunology Clinical Services. J Allergy Clin Immunol Pract. 2020 Jul - Aug; 8(7):2125-2134.
Score: 0.221
-
Health and Economic Outcomes of Home Maintenance Allergen Immunotherapy in Select Patients with High Health Literacy during the COVID-19 Pandemic: A Cost-Effectiveness Analysis During Exceptional Times. J Allergy Clin Immunol Pract. 2020 Jul - Aug; 8(7):2310-2321.e4.
Score: 0.220
-
Comparison of practice patterns among Canadian allergists before and after NIAID guideline recommendations. J Allergy Clin Immunol Pract. 2019 Nov - Dec; 7(8):2901-2903.e3.
Score: 0.206
-
Early Solid Food Introduction: Role in Food Allergy Prevention and Implications for Breastfeeding. J Pediatr. 2017 05; 184:13-18.
Score: 0.177